The Four Foods That Actually Help You Live Longer

And Why Most Supplements and Medications Don’t

If you’ve wandered through the supplement aisle of any pharmacy lately, you’ve probably noticed shelves groaning with bottles promising to extend your life, protect your heart, or ward off cancer. Fish oil. Vitamin E. Glucosamine. Resveratrol. NAD+ boosters. The global supplement industry is now worth over $150 billion, fueled by the seductive promise that the right pill might add years to your life.

Here’s what the research actually shows: most of these products do nothing. Some may actually shorten your life. And the things that genuinely reduce your risk of dying are so ordinary, so unglamorous, that they don’t even require a trip to the pharmacy.

After reviewing dozens of meta-analyses encompassing millions of participants, a clear picture emerges. Only four dietary factors have robust, consistent evidence for reducing all-cause mortality in healthy people: fiber, nuts, coffee, and tea. Everything else, from fish oil to aspirin to vitamin E, either lacks evidence of benefit or, in some cases, appears to cause harm.

The Boring Truth: Four Foods That Actually Work

Fiber: The Champion You’re Probably Not Eating Enough Of

Fiber isn’t sexy. It doesn’t come in a sleek bottle with bold claims. But it has the strongest mortality evidence of any dietary factor studied. A 2023 meta-analysis of 64 prospective cohort studies, covering 3.5 million people, found that those with the highest fiber intake had a 23% lower risk of dying from any cause compared to those with the lowest intake. Cardiovascular deaths dropped by 26%. Cancer deaths fell by 22%.

The optimal intake appears to be 25 to 29 grams per day, roughly twice what most Americans actually consume. Fiber from whole grains, cereals, and vegetables showed the strongest associations. This isn’t a pill you can take; it’s a pattern of eating you have to build.

Nuts: A Handful of Longevity

The evidence on nuts is remarkably consistent. A meta-analysis of 20 prospective studies found that one daily serving of nuts (about 28 grams, or a small handful) was associated with a 22% lower risk of all-cause mortality, a 25% lower risk of cardiovascular death, and a 15% lower risk of cancer death. The benefits were similar for tree nuts and peanuts.

Researchers estimate that 4.4 million deaths globally each year are attributable to nut intake below 20 grams daily. That’s a staggering toll from simply not eating enough of something our grandparents considered ordinary.

Coffee: Your Morning Habit (In Moderation) Is Probably Good for You

For decades, coffee was viewed with suspicion: too much caffeine, too acidic, probably bad for your heart. The data tell a different story. A meta-analysis of 40 prospective studies covering nearly 4 million participants found that coffee drinkers have about a 15% lower risk of death from any cause. The sweet spot appears to be 3 to 4 cups per day. Interestingly, decaffeinated coffee shows similar benefits, suggesting the effect isn’t primarily about caffeine.

The mortality benefit held up across different ages, weights, and smoking statuses. Black coffee and coffee with modest additions showed the clearest benefits. Loading it with sugar and cream diminishes the effect.

Tea: The World’s Second Beverage Delivers

A 2024 meta-analysis of 38 cohort studies, covering nearly 2 million participants, found that tea drinkers have a 10% lower risk of dying from any cause. Cardiovascular mortality was 14% lower. The benefits were strongest at 1.5 to 2 cups per day, with no additional benefit from drinking more. Both green and black tea appear effective.

UK Biobank data on nearly 500,000 people confirmed these findings specifically among black tea drinkers, an important finding because most prior research focused on green tea in Asian populations.

Why These Four? A Pattern Emerges

What do fiber, nuts, coffee, and tea have in common? They’re all whole foods (or minimally processed beverages) rich in polyphenols, antioxidants, and other bioactive compounds that work together in ways we don’t fully understand. They’ve been consumed by humans for thousands of years. And critically, they’re foods, not isolated compounds extracted into pills.

This last point matters. When researchers extract a single compound from a food (say, the catechins from green tea or the resveratrol from red wine) and put it in a capsule, it often doesn’t work. The compound may need the other components of the food to be absorbed properly, or the beneficial effect may come from the interaction of dozens of compounds. Food is complicated. Pills are simple. And biology favors complicated.

The Supplement Graveyard: What Doesn’t Work

Fish Oil

Fish oil is one of the most popular supplements in America, taken by roughly 19 million adults. The hope is that omega-3 fatty acids will protect the heart, just as eating fish seems to do. But when the Cochrane Collaboration (the gold standard for medical evidence synthesis) reviewed 79 randomized controlled trials involving over 112,000 people, they found “high-quality evidence that long-chain omega-3 fats do not have important positive or negative effects on mortality.” The risk ratio was 0.98, essentially identical to placebo.

The massive VITAL trial, which followed nearly 26,000 healthy Americans taking either fish oil or a placebo for five years, found no reduction in major cardiovascular events or all-cause mortality. Eating fish appears beneficial. Taking fish oil pills does not appear to replicate that benefit.

Vitamin D

This is a special case. Observational studies consistently show that people with low vitamin D levels have higher mortality. But when researchers conduct randomized trials giving vitamin D supplements to people, the benefit largely disappears. A 2019 meta-analysis of 21 randomized trials involving over 83,000 participants found no significant effect on major cardiovascular events or all-cause mortality.

There is one bright spot: vitamin D supplementation appears to reduce cancer mortality by about 16%, but only when supplementation lasts more than 3 years. For people who are genuinely deficient, supplementation makes sense. But for the general healthy population, the evidence for mortality benefit is weak.

Aspirin

For decades, many healthy adults took a daily low-dose aspirin hoping to prevent heart attacks. That advice has now been reversed. Meta-analyses of 13 randomized trials involving over 164,000 people consistently find that aspirin does not reduce all-cause mortality in people without existing cardiovascular disease (risk ratio 0.98, not statistically significant). Meanwhile, aspirin significantly increases the risk of major bleeding by 47%.

Most concerning was the ASPREE trial, which followed 19,000 healthy adults aged 65 and older. Aspirin users actually had slightly higher mortality, driven partly by increased cancer deaths, the opposite of what earlier observational studies suggested. The U.S. Preventive Services Task Force now recommends against routine aspirin use for primary prevention in adults 60 and older.

Glucosamine

Glucosamine made headlines when UK Biobank data showed that users had a 15% lower mortality rate. But a critical 2022 analysis exposed the flaw: glucosamine users were simply healthier people to begin with. They exercised more, smoked less, ate better, and had higher incomes. When researchers properly accounted for this “healthy user bias,” the apparent mortality benefit disappeared entirely. No randomized trials have ever tested whether glucosamine extends life. The observational associations may be entirely spurious.

The Supplements That May Actually Harm You

Some supplements don’t just fail to help; they appear to increase mortality. The Cochrane Collaboration’s analysis of antioxidant supplements, based on 78 randomized trials involving nearly 300,000 participants, found that beta-carotene supplementation increased mortality by 5-7%. High-dose vitamin E (400 IU or more daily) increased mortality by about 4%. These aren’t theoretical risks; they translate to tens of thousands of excess deaths.

The most likely explanation is that these isolated antioxidants disrupt the body’s natural signaling systems, which use reactive oxygen species for important cellular functions. It’s a cautionary tale about assuming that if some of a nutrient is good, more must be better.

What About Metformin and Other “Anti-Aging” Drugs?

Metformin, the diabetes drug, has generated enormous excitement in longevity circles because diabetics taking it appear to live as long as (or longer than) non-diabetics. But here’s the critical point: there are no randomized controlled trials of metformin in healthy non-diabetic people. The planned TAME (Targeting Aging with Metformin) trial, which would test this directly, has struggled to secure funding and has not yet been launched.

Recent evidence has been less encouraging. A 2023 Welsh study following diabetics on metformin for 20 years found that any early mortality benefit disappeared over time. A 2025 review titled “Emerging uncertainty on the anti-aging potential of metformin” noted that the drug “has generally not demonstrated its anticipated benefits in most clinical trials in nondiabetic populations.” The longevity promise may be overstated.

The Uncomfortable Conclusion

The research points to an uncomfortable truth: you cannot buy longevity in a bottle. The things that genuinely extend life are boring, slow, and require sustained effort. Eat more fiber. Snack on nuts instead of chips. Drink coffee or tea. These aren’t quick fixes; they’re patterns of living that compound over decades.

Meanwhile, most supplements either do nothing or cause harm. The few medications that reduce mortality (statins, blood pressure drugs, SGLT2 inhibitors) only do so in people who already have disease or significant risk factors. For a healthy person, the evidence is clear: focus on food, not pills.

The supplement industry thrives on hope, complexity, and the seductive idea that scientists have discovered a shortcut. But biology doesn’t work that way. Our Creator optimized us for whole foods, not isolated compounds. After reviewing millions of person-years of data, the conclusion is almost embarrassingly simple: eat plants, drink coffee, and put the supplements back on the shelf.

References

  1. Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;11(11):CD003177.
  2. Aune D, Keum N, Giovannucci E, et al. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14(1):207.
  3. Bao Y, Han J, Hu FB, et al. Association of nut consumption with total and cause-specific mortality. N Engl J Med. 2013;369(21):2001-2011.
  4. Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019;4(8):765-776.
  5. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012;(3):CD007176.
  6. Chung M, Zhao N, Wang D, et al. Dose-response relation between tea consumption and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of population-based studies. Adv Nutr. 2020;11(4):790-814.
  7. Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER 3rd. Enough is enough: stop wasting money on vitamin and mineral supplements. Ann Intern Med. 2013;159(12):850-851.
  8. Kim Y, Je Y. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019;34(8):731-752.
  9. Kim Y, Je Y. Tea consumption and risk of all-cause, cardiovascular disease, and cancer mortality: a meta-analysis of thirty-eight prospective cohort data sets. Epidemiol Health. 2024;46:e2024056.
  10. Mahmoud AN, Gad MM, Elgendy AY, Elgendy IY, Bavry AA. Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur Heart J. 2019;40(7):607-617.
  11. Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019;380(1):23-32.
  12. Manson JE, Bassuk SS, Buring JE; VITAL Research Group. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol. 2020;198:105522.
  13. Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024.
  14. Ramezani F, Pourghazi F, Eslami M, et al. Dietary fiber intake and all-cause and cause-specific mortality: an updated systematic review and meta-analysis of prospective cohort studies. Clin Nutr. 2024;43(1):65-83.
  15. Veronese N, Demurtas J, Pesolillo G, et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020;59(1):263-272.
  16. Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15(4):725-737.
  17. Zheng JS, Sharp SJ, Imamura F, et al. Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries. BMJ. 2020;370:m2194.